BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20603643)

  • 1. Cellular processing determinants for the activation of damage signals in response to topoisomerase I-linked DNA breakage.
    Huang TH; Chen HC; Chou SM; Yang YC; Fan JR; Li TK
    Cell Res; 2010 Sep; 20(9):1060-75. PubMed ID: 20603643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses.
    Fan JR; Huang TH; Wen CY; Shen TL; Li TK
    Eur J Pharmacol; 2010 Jul; 638(1-3):13-20. PubMed ID: 20406630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of phosphatidylinositol 3-kinase-related protein kinases in hyperphosphorylation of replication protein A2 in response to replication-mediated DNA double-strand breaks.
    Sakasai R; Shinohe K; Ichijima Y; Okita N; Shibata A; Asahina K; Teraoka H
    Genes Cells; 2006 Mar; 11(3):237-46. PubMed ID: 16483312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.
    Fan JR; Peng AL; Chen HC; Lo SC; Huang TH; Li TK
    DNA Repair (Amst); 2008 Mar; 7(3):452-63. PubMed ID: 18206427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling.
    Wiegman EM; Blaese MA; Loeffler H; Coppes RP; Rodemann HP
    Radiother Oncol; 2007 Jun; 83(3):289-95. PubMed ID: 17560675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968.
    Zuco V; Benedetti V; Zunino F
    Cancer Lett; 2010 Jun; 292(2):186-96. PubMed ID: 20042274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks.
    Sordet O; Redon CE; Guirouilh-Barbat J; Smith S; Solier S; Douarre C; Conti C; Nakamura AJ; Das BB; Nicolas E; Kohn KW; Bonner WM; Pommier Y
    EMBO Rep; 2009 Aug; 10(8):887-93. PubMed ID: 19557000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of S-phase progression triggered by UVA-induced ROS does not require a functional DNA damage checkpoint response in mammalian cells.
    Girard PM; Pozzebon M; Delacôte F; Douki T; Smirnova V; Sage E
    DNA Repair (Amst); 2008 Sep; 7(9):1500-16. PubMed ID: 18603484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
    Wei F; Xie Y; Tao L; Tang D
    Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-radiation-induced ATM-dependent signalling in human T-lymphocyte leukemic cells, MOLT-4.
    Tichý A; Záskodová D; Rezácová M; Vávrová J; Vokurková D; Pejchal J; Vilasová Z; Cerman J; Osterreicher J
    Acta Biochim Pol; 2007; 54(2):281-7. PubMed ID: 17565390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
    Gibson SL; Bindra RS; Glazer PM
    Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription-dependent activation of ataxia telangiectasia mutated prevents DNA-dependent protein kinase-mediated cell death in response to topoisomerase I poison.
    Sakasai R; Teraoka H; Takagi M; Tibbetts RS
    J Biol Chem; 2010 May; 285(20):15201-15208. PubMed ID: 20304914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
    Tomicic MT; Kaina B
    Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes.
    Shao RG; Cao CX; Zhang H; Kohn KW; Wold MS; Pommier Y
    EMBO J; 1999 Mar; 18(5):1397-406. PubMed ID: 10064605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distinctive cellular responses to DNA strand breaks caused by a DNA topoisomerase I poison in conjunction with DNA replication and RNA transcription.
    Sakasai R; Iwabuchi K
    Genes Genet Syst; 2016; 90(4):187-94. PubMed ID: 26616758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.
    Cristini A; Park JH; Capranico G; Legube G; Favre G; Sordet O
    Nucleic Acids Res; 2016 Feb; 44(3):1161-78. PubMed ID: 26578593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
    Ando K; Shah AK; Sachdev V; Kleinstiver BP; Taylor-Parker J; Welch MM; Hu Y; Salgia R; White FM; Parvin JD; Ozonoff A; Rameh LE; Joung JK; Bharti AK
    Oncotarget; 2017 Jul; 8(27):43733-43751. PubMed ID: 28415827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac.
    Wartlick F; Bopp A; Henninger C; Fritz G
    Biochim Biophys Acta; 2013 Dec; 1833(12):3093-3103. PubMed ID: 23999236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.